141 related articles for article (PubMed ID: 18092135)
41. Endometrioma presenting as a cavitary lung mass with intense 18F-FDG uptake on PET-CT.
Derman AY; Sperling D; Merav A; Jain VR; Levin M; Jana S; Haramati LB
J Thorac Imaging; 2007 May; 22(2):172-5. PubMed ID: 17527123
[TBL] [Abstract][Full Text] [Related]
42. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
Nishiyama Y; Yamamoto Y; Fukunaga K; Takinami H; Iwado Y; Satoh K; Ohkawa M
J Nucl Med; 2006 Oct; 47(10):1571-6. PubMed ID: 17015889
[TBL] [Abstract][Full Text] [Related]
43. Application of oral contrast media in coregistered positron emission tomography-CT.
Dizendorf EV; Treyer V; Von Schulthess GK; Hany TF
AJR Am J Roentgenol; 2002 Aug; 179(2):477-81. PubMed ID: 12130457
[TBL] [Abstract][Full Text] [Related]
44. Does reducing CT artifacts from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer?
Nahmias C; Lemmens C; Faul D; Carlson E; Long M; Blodgett T; Nuyts J; Townsend D
J Nucl Med; 2008 Jul; 49(7):1047-52. PubMed ID: 18552154
[TBL] [Abstract][Full Text] [Related]
45. [Evaluation of positron emission tomography in diagnosing and staging of lung cancer].
Zhu ZH; Zhou Q; Li LY; Cui RX; Cheng WY; Li YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):365-8. PubMed ID: 12940078
[TBL] [Abstract][Full Text] [Related]
46. Characterization of thymic masses using (18)F-FDG PET-CT.
Kumar A; Regmi SK; Dutta R; Kumar R; Gupta SD; Das P; Halanaik D; Jindal T
Ann Nucl Med; 2009 Aug; 23(6):569-77. PubMed ID: 19585212
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic evaluation of separately acquired PET and CT images by nuclear medicine physicians and radiologists in cancer patients.
Quarles van Ufford HM; Quekel LG; van Waes PF; de Haas PJ; de Klerk JM
Hell J Nucl Med; 2007; 10(2):105-8. PubMed ID: 17684586
[TBL] [Abstract][Full Text] [Related]
48. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.
Antoch G; Freudenberg LS; Egelhof T; Stattaus J; Jentzen W; Debatin JF; Bockisch A
J Nucl Med; 2002 Oct; 43(10):1339-42. PubMed ID: 12368372
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.
Otero HJ; Yap JT; Patak MA; Erturk SM; Israel DA; Johnston CJ; Sakellis C; Rybicki FJ; Van den Abbeele AD; Ros PR
AJR Am J Roentgenol; 2009 Aug; 193(2):326-32. PubMed ID: 19620427
[TBL] [Abstract][Full Text] [Related]
50. Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings.
Farsad M; Ambrosini V; Nanni C; Castellucci P; Boschi S; Rubello D; Fabbri M; Franchi R; Fanti S
Nucl Med Commun; 2005 Sep; 26(9):827-30. PubMed ID: 16096587
[TBL] [Abstract][Full Text] [Related]
51. The effect of oral contrast on large bowel activity in FDG-PET/CT.
Otsuka H; Graham MM; Kubo A; Nishitani H
Ann Nucl Med; 2005 Apr; 19(2):101-8. PubMed ID: 15909489
[TBL] [Abstract][Full Text] [Related]
52. Two cases of pulmonary paragonimiasis on FDG-PET CT imaging.
Yoo IeR; Park HJ; Hyun J; Chung YA; Sohn HS; Chung SK; Kin SH
Ann Nucl Med; 2006 May; 20(4):311-5. PubMed ID: 16856575
[TBL] [Abstract][Full Text] [Related]
53. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
Okuma T; Matsuoka T; Okamura T; Wada Y; Yamamoto A; Oyama Y; Koyama K; Nakamura K; Watanabe Y; Inoue Y
J Nucl Med; 2006 Aug; 47(8):1351-8. PubMed ID: 16883016
[TBL] [Abstract][Full Text] [Related]
54. How much intravenous contrast is needed in FDG-PET/CT?
Strobel K; Thuerl CM; Hany TF
Nuklearmedizin; 2005; 44 Suppl 1():S32-7. PubMed ID: 16395976
[TBL] [Abstract][Full Text] [Related]
55. Standardized uptake values of normal organs on 18F-fluorodeoxyglucose positron emission tomography and computed tomography imaging.
Zincirkeser S; Sahin E; Halac M; Sager S
J Int Med Res; 2007; 35(2):231-6. PubMed ID: 17542410
[TBL] [Abstract][Full Text] [Related]
56. Anterior layering of excreted 18F-FDG in the bladder on PET/CT: frequency and cause.
Purcell DD; Coakley FV; Franc BL; Hawkins RA; Boddington SE; Yeh BM
AJR Am J Roentgenol; 2007 Aug; 189(2):W96-9. PubMed ID: 17646448
[TBL] [Abstract][Full Text] [Related]
57. Primary hepatic angiosarcoma on coregistered FDG PET and CT images.
Maeda T; Tateishi U; Hasegawa T; Ojima H; Arai Y; Sugimura K
AJR Am J Roentgenol; 2007 Jun; 188(6):1615-7. PubMed ID: 17515384
[No Abstract] [Full Text] [Related]
58. Spectrum of focal benign musculoskeletal 18F-FDG uptake at PET/CT of the shoulder and pelvis.
Sopov V; Bernstine H; Stern D; Yefremov N; Sosna J; Groshar D
AJR Am J Roentgenol; 2009 Apr; 192(4):1029-35. PubMed ID: 19304710
[TBL] [Abstract][Full Text] [Related]
59. Fixation devices for whole-body 18F-FDG PET/CT: patient perspectives and technical aspects.
Brechtel K; Heners H; Mueller M; Aschoff P; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
Nucl Med Commun; 2007 Feb; 28(2):141-7. PubMed ID: 17198356
[TBL] [Abstract][Full Text] [Related]
60. Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials.
Antoch G; Freudenberg LS; Stattaus J; Jentzen W; Mueller SP; Debatin JF; Bockisch A
AJR Am J Roentgenol; 2002 Dec; 179(6):1555-60. PubMed ID: 12438054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
